EMA Authorised: Ivabradine Anpharm (ivabradine) — "Anpharm" Przedsiębiorstwo Farmaceutyczne S.A.

View source ↗

Summary

The European Medicines Agency authorised a new ivabradine product, Ivabradine Anpharm, by Anpharm Przedsiębiorstwo Farmaceutyczne S.A., for treatment of angina …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Heart Failure

Drugs mentioned

• Ivabradine Anpharm (ivabradine)

Snippet

Status: Authorised. Therapeutic area: Angina Pectoris;Heart Failure. MAH: "Anpharm" Przedsiębiorstwo Farmaceutyczne S.A.. Decision date: 17/11/2025